{
  "data": [
    {
      "question": "What is the empirical formula and formula weight of compound 2?",
      "answer": "Empirical formula: C28H38Cl4Cu2N6O2, Formula weight: 759.52",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "Which crystal system does compound 4 belong to, and what is its space group?",
      "answer": "Crystal system: Monoclinic, Space group: P21/n",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "What are the crystal size dimensions of compound 9?",
      "answer": "Crystal size dimensions of compound 9 are 0.15x0.11x0.05 mm",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "For compound 7, what is the value of β in degrees?",
      "answer": "For compound 7, the value of β is 109.670(2) degrees",
      "difficulty": "hard",
      "type": "factual"
    },
    {
      "question": "What is the method used for the stability constants determination of Cu(II) complexes?",
      "answer": "The method used for the stability constants determination of Cu(II) complexes is spectrophotometric titrations in the visible range (400 – 900 nm).",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "How was the intracellular copper content determined in the cell cultures treated with copper complexes?",
      "answer": "The intracellular copper content in the cell cultures treated with copper complexes was determined using ICP-AES (inductively coupled plasma atomic emission spectroscopy).",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "What is the relationship between hydrophobicity and cytotoxic activity of copper complexes as shown in Fig. S9?",
      "answer": "The relationship between hydrophobicity and cytotoxic activity of copper complexes is represented by nonlinear regression curves, indicating that for each group of compounds, there is an optimal logP value at which activity is maximal.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "Is the copper complex of disulfiram (CuDSF) effective in inducing cytoplasmic vacuolization in HT1080 and HeLa cells?",
      "answer": "Yes, the copper complex of disulfiram (CuDSF) is effective in inducing cytoplasmic vacuolization in HT1080 and HeLa cells, as shown in Fig. S11.",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "Does the copper complex of histidine (Cu(His)2) induce cytoplasmic vacuolization in HT1080 and HeLa cells?",
      "answer": "No, the copper complex of histidine (Cu(His)2) does not induce cytoplasmic vacuolization in HT1080 and HeLa cells, as indicated in Fig. S11.",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "Can the copper complex of clioquinol (Cu(CQ)2) induce paraptotic morphology in cancer cells?",
      "answer": "Yes, the copper complex of clioquinol (Cu(CQ)2) can induce paraptotic morphology in cancer cells, as indicated by the presence of cytoplasmic vacuolization.",
      "difficulty": "medium",
      "type": "True or False"
    }
  ]
}
